Astria Therapeutics Inc (NASDAQ:ATXS) shares, rose in value on Wednesday, June 18, with the stock price up by 3.33% to the previous day’s close as strong demand from buyers drove the stock to $5.89.
Actively observing the price movement in the last trading, the stock closed the session at $5.70. Referring to stock’s 52-week performance, its high was $12.92, and the low was $3.56. On the whole, ATXS has fluctuated by 38.26% over the past month.
With the market capitalization of Astria Therapeutics Inc currently standing at about $332.40 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATXS’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ATXS currently trading nearly 14.98% and 24.76% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.85, while the 7-day volatility ratio is showing 3.54% which for the 30-day chart, stands at 5.66%. Furthermore, Astria Therapeutics Inc (ATXS)’s beta value is 0.38, and its average true range (ATR) is 0.44.
A comparison of Astria Therapeutics Inc (ATXS) with its peers suggests the former has fared considerably weaker in the market. ATXS showed an intraday change of 3.33% in last session, and over the past year, it shrunk by -35.63%%.
Data on historical trading for Astria Therapeutics Inc (NASDAQ:ATXS) indicates that the trading volumes over the past 3 months, they’ve averaged 483.57K. According to company’s latest data on outstanding shares, there are 56.43 million shares outstanding.
Nearly 19.25% of Astria Therapeutics Inc’s shares belong to company insiders and institutional investors own 84.70% of the company’s shares. The stock has fallen by -34.12% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATXS stock heading into the next quarter.
